NRX Pharmaceuticals, Inc. Common Stock(NRXP)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$3.99
52-Week Range
$1.62 – $5.05
YTD
+52.29%
IV Rank (30D)
38.19
Straddle Price
$1.75
P/C Vol Ratio
0.40
Market Cap
$0.2B
Fair Value
-13.2% vs price
Confidence: 20% Alpha Score: 0.08

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.41%
Beta vs SPY1.00
Cost of Equity (CAPM)9.91% (VRP-adj)
WACC10.05%
Volatility Risk Premium+103.9pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)177.6%
Book / Price-15.8%
Gross Margin (TTM)50.5%
FCF Margin (TTM)-650.9%
Quality Score2/6 — normal (10y DCF)
SMA 50$3.48 (Market Anchor value)
SMA 20 / Bollinger Mid$4.01
Bollinger Width / SMA20730.9% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Blended Fair Value
$3.48
Current Price
$4.00
Deviation
-13.2%
Forward-Return Rank SHORT gates ✓
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -3.9% +0.06 -0.52 74.2%
42d -5.0% +0.19 -0.52 74.2%
63d -5.5% +0.12 -0.52 74.2%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0%
Peer P/S n/a 0%
Market Anchor (SMA50) $3.48 100% stability 60% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-29 · updated 2026-06-29 18:01:31.397000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.2B

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -6.97% 5
Feb -10.50% 5
Mar -3.94% 5
Apr -10.20% 5
May +19.15% 6
Jun -18.28% 6
Jul +5.40% 5
Aug -17.44% 5
Sep -2.07% 5
Oct +2.25% 5
Nov +6.53% 5
Dec +10.64% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $3.99
SMA 50: $3.51
SMA 200: $2.69
Current: $4.00
EMA 12: $3.84
EMA 26: $3.78
MACD: 0.0631 | Signal: -0.0632
BULLISH
ADX (14): 19.80
RANGE
+DI: 19.78
−DI: 25.48
Momentum Oscillators
RSI (14): 56.17
NEUTRAL
Stoch %K: 51.15
Stoch %D: 41.79
Williams %R: -30.38
Volume & Volatility
BB Upper: $4.54
BB Lower: $3.43
NEUTRAL
OBV: 54,990,837
Vol SMA 20: 1,421,002
Vol ROC: 28.07%
ATR: $0.35
True Range: $0.33
HV 20: 84.0%
HV 30: 112.7%
HV 60: 100.1%

Data Summary
Data Points: 500
Last Updated: 2026-06-29T18:00:27.122000
Date Range: 2024-06-28T00:00:00 – 2026-06-26T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
5 of 5 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-15 Pre-Market 246.31% 8.87% 0.04x Within
2024-11-15 Pre-Market 207.63% 1.69% 0.01x Within
2025-03-21 After-Close 18.87% 3.77% 0.20x Within
2025-05-21 After-Close 43.00% 7.60% 0.18x Within
2025-08-18 After-Close 31.70% 5.80% 0.18x Within
Options Activity
IV Rank (30D)
38.19
IV Rank (7D)
38.19
Avg IV
229.4%
Straddle (30D)
$1.75
Straddle (7D)
$1.75
P/C Volume
0.40
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
2.13
Correlation (SPY)
30.6%
0.09
Ann. Volatility
87.2%
SPY Volatility
12.5%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 23,473,095 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

33 filers5,639,216 shares$12.45M value24.02% of float
# Filer Shares Value % of Total % of Float Period
1 B Group, Inc. 3,000,000 $6.39M 51.34% 12.78% 2026-03-31
2 VANGUARD GROUP INC Custodian 729,842 $1.98M 15.89% 3.11% 2025-12-31
3 AdvisorShares Investments LLC 420,467 $895.60K 7.20% 1.79% 2026-03-31
4 COMMONWEALTH EQUITY SERVICES, LLC 397,431 $846.53K 6.80% 1.69% 2026-03-31
5 GEODE CAPITAL MANAGEMENT, LLC Custodian 310,112 $660.61K 5.31% 1.32% 2026-03-31
6 Bleakley Financial Group, LLC 117,204 $249.65K 2.01% 0.50% 2026-03-31
7 BlackRock, Inc. Custodian 98,995 $210.86K 1.69% 0.42% 2026-03-31
8 STATE STREET CORP 86,984 $185.28K 1.49% 0.37% 2026-03-31
9 XTX Topco Ltd 78,733 $167.70K 1.35% 0.34% 2026-03-31
10 Global Retirement Partners, LLC 39,300 $106.50K 0.86% 0.17% 2025-12-31
11 One Wealth Management Investment & Advisory Services, LLC 37,873 $102.64K 0.82% 0.16% 2025-12-31
12 Chicago Partners Investment Group LLC 34,479 $102.40K 0.82% 0.15% 2026-03-31
13 JANE STREET GROUP, LLC Custodian 44,152 $94.04K 0.76% 0.19% 2026-03-31
14 NORTHERN TRUST CORP Custodian 43,469 $92.59K 0.74% 0.19% 2026-03-31
15 Headlands Technologies LLC 39,394 $83.91K 0.67% 0.17% 2026-03-31
16 AXQ CAPITAL, LP 33,211 $70.74K 0.57% 0.14% 2026-03-31
17 UBS Group AG Custodian 25,227 $53.73K 0.43% 0.11% 2026-03-31
18 Schonfeld Strategic Advisors LLC 19,876 $42.34K 0.34% 0.08% 2026-03-31
19 Ethos Financial Group, LLC 15,900 $33.87K 0.27% 0.07% 2026-03-31
20 SJBENEN ADVISORY, LLC 15,000 $31.95K 0.26% 0.06% 2026-03-31
21 MORGAN STANLEY Custodian 10,029 $27.18K 0.22% 0.04% 2025-12-31
22 SBI Securities Co., Ltd. 2,500 $5.33K 0.04% 0.01% 2026-03-31
23 WELLS FARGO & COMPANY/MN Custodian 2,350 $5.01K 0.04% 0.01% 2026-03-31
24 ROYAL BANK OF CANADA Custodian 2,509 $5.00K 0.04% 0.01% 2026-03-31
25 SUMMIT SECURITIES GROUP LLC 1,135 $2.42K 0.02% <0.01% 2026-03-31
4 filers$280.51K notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $148.46K 52.92% 2026-03-31
2 JANE STREET GROUP, LLC Custodian $77.96K 27.79% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $52.61K 18.76% 2026-03-31
4 Chicago Partners Investment Group LLC $1.49K 0.53% 2026-03-31
2 filers$282.01K notional
# Filer Notional Value % of Total Period
1 JANE STREET GROUP, LLC Custodian $212.79K 75.45% 2026-03-31
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $69.22K 24.55% 2026-03-31
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio-11.0
P/S Ratio66.5
EV/EBITDA-8.5
TTM Revenue$0.0B
TTM Net Income$-0.0B
TTM EPS$-1.09
ROE177.6%